Evidence map›Paper›PMID 41428969›Full record

ArticleJCO clinical cancer informatics2025

SmokeBERT and Beyond: Bridging Clinical Narratives and Structured Smoking Data to Improve Lung Cancer Screening.

Heng Tan, Travis J Osterman

Abstract readEditorial
In one paragraph

Article in JCO clinical cancer informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Heng TanVanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-8211-1083
Travis J OstermanVanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2841-8121

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanUH3CA260318 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Tuya Pal · 2023 to 2026
$8.6M
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanUG3CA260318 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FRIEDMAN, DEBRA L., PAL, TUYA · 2021 to 2022
$2.1M
Implementation science to scale and sustain tobacco treatment leveraging point of care paradigm and health information technologyUG3CA305777 · NCI · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C, CHEN, LI-SHIUN · 2025 to 2025
$1.6M
NCI NIH HHS P30 CA068485NCI NIH HHS UG3 CA260318NCI NIH HHS UG3 CA305777NCI NIH HHS UH3 CA260318
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41428969
PMCPMC12782282

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.